News About: Pharm. Industry
Domestic pharmaceutical companies are keeping eyes on gigantic hepatitis B drugs to catch the right moment
Domestic pharmaceutical companies in Korea have concentrated on launches of follow-up drugs for Baraclude(BMS) and Viread(Gilead), which divide the hepatitis B drug market into two parts.
Baraclude is in the state wh...
Direct dealings of pharmaceutical companies with pharmacies disturb invigoration of OTC drugs
Although the entire pharmaceutical industry, such as manufacturing, wholesale and pharmacies, is actively working on invigoration of OTC (Over The Counter) drugs, it has not had any accomplishment, yet.
The pharmaceu...
Pharmaceutical companies are moving forward to raise funds… Handok’s purpose is ‘Debt Repayment’There have been continuous actions to raise funds among domestic pharmaceutical companies in Korea. While Hanmi Pharmaceutical recapitalized KRW 100 billion to secure funds for ...
|
6 pharmaceutical companies are challenging on the exclusive sale rights for Ezetimibe
While domestic pharmaceutical companies in Korea are competing for the Rosuvastatin-Ezetimibe complex, competition for patent on the complex has opened up as well.
Especially, since the exclusive sale rights will be ...
For the job opening of the Sanofi’s Marketing Department head, veterans in the industry were shouting “Me, ME!”
Formidable veterans in the pharmaceutical industry have competed for an opening for a marketing department head in a multinational pharmaceutical company.
According to the industry on the 30th, Sanofi-Aventis Korea r...
Pharmacies complains “Too much” over the Zuellig’s action requesting for excessive personal information and providing the information to pharmaceutical companies
Controversy of Zuellig Pharma Korea requesting client pharmacies for excessive personal information and providing pharmaceutical companies with the information has been raised.
According to the Zuellig Pharma Korea’s...
Suspicious intention of Pfizer Korea for a golf gathering with its wholesale clients
It was known that Pfizer Korea, become the public enemy in the pharmaceutical distribution industry due to its distribution price lower than the break-even point, invited its wholesale clients to a golf club in Cheona...
The Korean pharmaceutical industry is expected to recover next year… various restrictions will be finalized soon
The Korean pharmaceutical industry, which had a huge hit by the across-the-nation drug price reduction in 2012, is expected to recover with single-digit increases next year.
Based on the ‘2015 Major Pharmaceutical Co...
What is the influence of the Hanmi Pharmaceutical’s sellout of Don-A ST’s stocks?Hanmi Pharmaceutical and Hanmi Science announced that they reduced the number of Dong-A ST’s stocks from 8.71% to 6.65%.
They sold the stocks in the stock market, and its only ...
|
.jpg)
Concern over a vicious cycle where loan controls of pharmaceutical companies lead to management difficulties of wholesalers
It is shown that a vicious cycle continues where pharmaceutical companies tighten up its loan controls, so wholesalers get hard in management, and therefore the loan controls get tightened up again. The phenomenon bec...
